ResMed (ASX:RMD) Stock on a tear Post Q12021 Results, Share Price up by ~9%

Summary

  • ASX 200-listed digital health company ResMed announced a strong first quarter of FY2021 with revenue and non-GAAP operating profit increasing by 10% and 24%, respectively.
  • The Q1 results reflect robust performance and positive trends across the Company’s business.
  • Revenue in Canada, Latin America, and the US grew by 9%, driven by solid sales in the mask product portfolio and growing demand for ventilators amid COVID-19.

The share price of ASX 200-listed ResMed Inc (ASX:RMD, NYSE:RMD) surged on the ASX following the impressive Q12021 numbers announced by the Company. During the quarter, ResMed’s year-over-year revenue increased by 10%, and non-GAAP operating profit rose 24%.

On 30 October 2020, the RMD share price stood at A$27.920, up by 9.8447%. The market capitalisation of the Company was noted at A$36.96 billion.

About ResMed Inc

Dual-listed digital health company, ResMed Inc, is a pioneer in innovative solutions to treat and keep people out of the hospital and empowers them to live better, healthier, and high-quality lives. The Company’s digital health technologies and cloud-connected medical devices transform care for patients of COPD, sleep apnea, and other chronic indications.

Let us look at ResMed’s Q1 results in detail:

ResMed’s First Quarter 2021 Results, Revenue up by 10%

On 30 October 2020, ResMed released its quarterly update for the September 2020 quarter on the ASX.

Highlights from the financial front-

  • Revenue during the September quarter was up 10% at US$751.9 million (+9% on a constant currency (cc) basis).
  • GAAP gross margin was 58.3% and non-GAAP gross margin expanded 30 bps to 59.9%.
  • The net operating profit grew by 27% while non-GAAP operating profit was up 24%.
  • Revenue in Canada, the US, and Latin America were up 9% (excluding Software as a Service). Impressive sales in the mask product portfolio and increased demand for ventilators amid COVID-19 were the revenue drivers.
  • Software as a Service (SaaS) revenue grew 6% due to the continuous growth in resupply service offerings and stabilising patient flow in out-of-hospital care settings.

Highlights from Business and Operational front-

  • The Company launched the AirTouch N20 foam CPAP mask, the softest nasal mask ever, with a memory foam cushion.
  • AirFit N30 and AirFit F30i masks received Good Design Australia Awards for attaining the maximum level of design and innovation in service to sleep apnea patients across the world.
  • ResMed has won eight Good Design Australia Awards.
  • Mick Farrell ResMed CEO was selected as Large Public Company CEO of the Year by the San Diego Business Journal.

CEO ResMed Mick Farrell commented-


Disclaimer
The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (Kalkine Media, we or us), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.

Ad

GET A FREE STOCK REPORT


Top Penny Picks under 20 Cents to Fit Your Pocket! Get Exclusive Report on Penny Stocks For FREE Now.


   

Kalkine

Rated 4.3/5 based on 904 Reviews at Google My Business
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK